The organizers of Prix Galien Russia today announced the official list of nominees for the Prix Galien Russia 2014 awards. Prix Galien is considered to be the biomedical industry’s highest honor to recognize scientific innovation for biopharmaceutical and medical technology products that improve the human condition.
This year’s ceremony will be held at the Pashkov House on October 23rd where the awards will be presented for this year’s five categories. Divided into two main groups, Biopharmaceuticals and Medical Technology, Prix Galien Russia 2014 counts with 33 total candidates across the following categories: Research in Russia, Pharmaceutical Agent, Biotechnology Product, Russian Medical Technology, and Medical Technology.
The nominees for the Prix Galien Russia 2014 awards are:
Research in Russia (Nominees)
Radachlorin® | RadaPharma |
Dipeptide strategy in Pharmacology | Zakusov Institute of Pharmacology |
Diaskintest® | CSJC “GENERIUM” |
Study of bacteriophages asalternatives to antibiotics | MIPT Life Science Center |
Zoleren® | PharmSintez |
Pharmaceutical Agent (Nominees)
Bedaquiline (Sirturo®) | Janssen |
Dabigatran etexilate (Pradaxa®) | Boehringer Ingelheim |
Perampanel (Fycompa®) | Eisai |
Ethinylestradiol+drospirenone+levomefolate (Yaz Plus®) | Bayer |
Pasireotide (Signifor®) | Novartis |
Eribulin (Halaven®) | Eisai |
Rifaximin (AlfaNormix®) | AlfaWassermann |
Rivaroxaban (Xarelto®) | Bayer |
Ticagrelor (Brilinta®) | Astra Zeneca |
Tofacitinib (Jakvinus®) | Pfizer |
Biotechnology Product (Nominees)
Abtacept (ORENCIA®) | Bristol-Myers Squibb |
Adalimumab (Humira®) | AbbVie |
Canakinumab (Ilaris®) | Novartis |
Denosumab (Xgeva®) | Amgen |
Interferon beta-1a (Rebif®) | Merck Serono |
Palivizumab (Synagis®) | AbbVie |
Pneumococcal 13-valentConjugate Vaccine (Prevenar®) | Pfizer |
Ruxolitinib (Jakavi®) | Novartis |
Teriparatide (Forsteo®) | Lilly |
Ustekinumab (Stelara®) | Janssen |
Russsian Medical Technology (Nominees)
Amycard-01C | Amycard |
Microarrays | Engelhardt Institute of Molecular Biology Russian Academy of Science |
Orphagene® | MIPT Life Science Center |
ThrombodynamicsAnalyser System T-2 | Hemacore |
Laser-based analyzer of exhaled air | The General Physics Instityte, named after Prokhorov |
Medical Technology (Nominees)
Ultrasonic Dissection Device(Sonicision®) | Covidien |
Bioresorbable vascular scaffold(Absorb®) | Abbott |
HPV Test (Cobas 4800®) | Roche Diagnostics |
“Building on our achievements last year, we are glad to have successfully added Medical Technology categories to Prix Galien Russia and augmenting the Jury by bringing in relevant specialists in that domain”, remarked Frédéric Boucheseiche, General Secretary of the Prix Galien Russia. “With the support of our partners we continue to foster biomedical innovation in Russia and hope that Russian Galien laureates will soon be recognized internationally as well.”
About Prix Galien Russia:
Prix Galien Russia was inaugurated in Moscow in October 2013 under the auspice of an exceptional awards committee composed of eminent specialists involved in the sphere of Russian and international pharmaceutical research.
Around the world, Prix Galien rewards outstanding achievements in improving the global human condition through the development of innovative therapies.
To attend or support the Prix Galien Russia 2014 awards ceremony or for sponsorship opportunities, please contact: prixgalien@focusreports.net